PPIG and neoplasm: Importantly, the tumor cell-specific activation of selective CYP enzyme function through GDEPT allows for the use of lower doses of already approved chemotherapy prodrugs due to the increased sensitivity of the modified cells, potentially reducing toxicity on healthy tissue while maintaining therapeutic efficacy, highlighting the importance of this approach in cancer therapy (Miura et al., 2015; Mishra et al., 2018).